Abstract:We read with interest the article by Ye and colleagues [1Ye B. Cheng M. Li W. et al.Predictive factors for lymph node metastasis in clinical stage Ia lung adenocarcinoma.Ann Thorac Surg. 2014; 98: 217-223Abstract Full Text Full Text PDF PubMed Scopus (74) Google Scholar] about the predictive factors for lymph node metastasis in clinical stage IA lung adenocarcinoma, in which they reported a 10.6% overall rate of lymph node metastasis.Theoretically, candidates for sublobar resection should be node negative; thus, it is important to improve the accuracy of clinical staging for cancer. According to the data of Ye and colleagues, factors such as ground-glass opacity status, serum carcinoembryonic antigen level, histologic subtype, and maximum standardized uptake value have potential for the prediction of lymph node metastasis. A prediction model based on some of these factors has been established to assess the possibility of lymph node metastasis in early-stage lung cancer [2Zhang Y. Sun Y. Xiang J. Hu H. Chen H. A prediction model for n2 disease in T1 non-small cell lung cancer.J Thorac Cardiovasc Surg. 2012; 144: 1360-1364Abstract Full Text Full Text PDF PubMed Scopus (56) Google Scholar]. Some issues are worth noting here. First, the specific histology subtype (eg, acinar predominant, micropapillary predominant) was a reliable predictive factor both in the study of Ye and colleagues and in other research [3Zhang Y. Sun Y. Shen L. et al.Predictive factors of lymph node status in small peripheral non-small cell lung cancers: tumor histology is more reliable.Ann Surg Oncol. 2013; 20: 1949-1954Crossref PubMed Scopus (47) Google Scholar]. However, for the majority of lung cancer patients, the histology subtype is a postoperative pathologic diagnosis that is difficult to determine before operation because of the lack of a sufficient tumor specimen, so the histology subtype is of limited value for excluding node-positive patients preoperatively. Second, according to their univariate analyses, the node metastasis rates for patients with individual risk factors were less than 20%, suggesting that these predictive factors are insufficiently efficient for excluding node-positive patients.Two approaches have potential value in selecting candidates for sublobar resection. One is to identify high-risk patients for lymph node metastasis, followed by mediastinal staging evaluation. The other is the use of lymphatic tracers for sentinel lymph node mapping. A clinical study has demonstrated that an indocyanine green fluorescence imaging system is feasible for use in sentinel node biopsy and has a high overall accuracy rate of 80.7% [4Yamashita S. Tokuishi K. Anami K. et al.Video-assisted thoracoscopic indocyanine green fluorescence imaging system shows sentinel lymph nodes in non-small-cell lung cancer.J Thorac Cardiovasc Surg. 2011; 141: 141-144Abstract Full Text Full Text PDF PubMed Scopus (69) Google Scholar]. Optimization of the imaging system and lymphatic tracers for the sentinel lymph nodes would provide an accurate means of determining the optimal candidates for sublobar resection. We eagerly await the further development and refinement of this technology.Again, we congratulate Ye and colleagues on this brilliant study. We are confident that this study will optimize the selection of candidates for either invasive mediastinal staging or sublobar resection. We read with interest the article by Ye and colleagues [1Ye B. Cheng M. Li W. et al.Predictive factors for lymph node metastasis in clinical stage Ia lung adenocarcinoma.Ann Thorac Surg. 2014; 98: 217-223Abstract Full Text Full Text PDF PubMed Scopus (74) Google Scholar] about the predictive factors for lymph node metastasis in clinical stage IA lung adenocarcinoma, in which they reported a 10.6% overall rate of lymph node metastasis. Theoretically, candidates for sublobar resection should be node negative; thus, it is important to improve the accuracy of clinical staging for cancer. According to the data of Ye and colleagues, factors such as ground-glass opacity status, serum carcinoembryonic antigen level, histologic subtype, and maximum standardized uptake value have potential for the prediction of lymph node metastasis. A prediction model based on some of these factors has been established to assess the possibility of lymph node metastasis in early-stage lung cancer [2Zhang Y. Sun Y. Xiang J. Hu H. Chen H. A prediction model for n2 disease in T1 non-small cell lung cancer.J Thorac Cardiovasc Surg. 2012; 144: 1360-1364Abstract Full Text Full Text PDF PubMed Scopus (56) Google Scholar]. Some issues are worth noting here. First, the specific histology subtype (eg, acinar predominant, micropapillary predominant) was a reliable predictive factor both in the study of Ye and colleagues and in other research [3Zhang Y. Sun Y. Shen L. et al.Predictive factors of lymph node status in small peripheral non-small cell lung cancers: tumor histology is more reliable.Ann Surg Oncol. 2013; 20: 1949-1954Crossref PubMed Scopus (47) Google Scholar]. However, for the majority of lung cancer patients, the histology subtype is a postoperative pathologic diagnosis that is difficult to determine before operation because of the lack of a sufficient tumor specimen, so the histology subtype is of limited value for excluding node-positive patients preoperatively. Second, according to their univariate analyses, the node metastasis rates for patients with individual risk factors were less than 20%, suggesting that these predictive factors are insufficiently efficient for excluding node-positive patients. Two approaches have potential value in selecting candidates for sublobar resection. One is to identify high-risk patients for lymph node metastasis, followed by mediastinal staging evaluation. The other is the use of lymphatic tracers for sentinel lymph node mapping. A clinical study has demonstrated that an indocyanine green fluorescence imaging system is feasible for use in sentinel node biopsy and has a high overall accuracy rate of 80.7% [4Yamashita S. Tokuishi K. Anami K. et al.Video-assisted thoracoscopic indocyanine green fluorescence imaging system shows sentinel lymph nodes in non-small-cell lung cancer.J Thorac Cardiovasc Surg. 2011; 141: 141-144Abstract Full Text Full Text PDF PubMed Scopus (69) Google Scholar]. Optimization of the imaging system and lymphatic tracers for the sentinel lymph nodes would provide an accurate means of determining the optimal candidates for sublobar resection. We eagerly await the further development and refinement of this technology. Again, we congratulate Ye and colleagues on this brilliant study. We are confident that this study will optimize the selection of candidates for either invasive mediastinal staging or sublobar resection. Predictive Factors for Lymph Node Metastasis in Clinical Stage IA Lung AdenocarcinomaThe Annals of Thoracic SurgeryVol. 98Issue 1PreviewSystematic lymph node dissection or sampling in all patients with clinical stage IA lung adenocarcinoma is currently controversial because the risk of lymph node metastasis is unclear. This study aimed to determine the predictive factors for lymph node metastasis in patients with clinical stage IA lung adenocarcinoma. Full-Text PDF

Role of pulmonary segmental and sub-segmental lymph nodes in pathological staging of lung cancer

Distribution and prognosis of mediastinal lymph node metastases of nonsmall cell lung cancer.

The Regularity and Clinical Significance of Intrapulmonary Lobar and Segmental Lymph Nodes Metastasis in Patients with Ct1n0m0 Stage Lung Adenocarcinoma

The pattern of lymph node metastasis in peripheral pulmonary nodules patients and risk prediction models

Preoperative Lymph Node Assessment in Surgically Resected Pathologic T1 Lung Cancer Patients: Real World Clinical Practice in China.

Predictive Risk Factors for Lymph Node Metastasis in Patients with Small Size Non-Small Cell Lung Cancer.

Prognostic Impact of Lymphadenectomy on Outcomes of Sublobar Resection for Stage IA Non–small Cell Lung Cancer ≤2 Cm

Lymph node dissection in small-sized pulmonary metastasectomy: Impact on the long-term survival

Novel Perspective to Evaluate the Safety of Segmentectomy: Clinical Significance of Lobar and Segmental Lymph Node Metastasis in Ct1n0m0 Lung Adenocarcinoma†

Lymph Node Metastasis in Clinical Stage IA Peripheral Lung Cancer.

Optimal Lung Cancer Candidates for Sublobar Resection: Prediction of Pathologic Node-Negative Clinical Stage IA NSCLC.

Effectiveness and Safety of Systematic and Selective Lymphadenectomies in Chinese Patients with Non-Small Cell Lung Cancer Who Received Sublobar Resection.

Predictors of Lymph Node Metastasis and Possible Selective Lymph Node Dissection in Clinical Stage IA Non-Small Cell Lung Cancer

The Extent of Mediastinal Lymph Node Dissection Correlates with Survival of Small Cell Lung Cancer Patients after Resection: a Propensity Score-Matched Cohort Study Analysis.

OA07.02 Omitting Intrapulmonary Lymph Node Retrieval May Affect the Oncological Outcome of Pn0 Lung Cancer Patients: A Propensity Score Match Analysis

Segment Location and Ground Glass Opacity Ratio Reliably Predict Node-Negative Status in Lung Cancer

Primary Study on Mediastinal Lymph Node Metastasis in Patients with ≤3 cm Peripheral Non-small Cell Lung Cancer

Association between number of dissected lymph nodes and survival in patients undergoing resection for clinical stage IA pure solid lung adenocarcinoma: a retrospective analysis

Lymph node dissection in lung cancer surgery

Analysis of the Relationship Between the Anatomical Location of Intrapulmonary Metastatic Lymph Nodes and Relapse Risk and Survival in Patients with N1 Non-Small Cell Lung Cancer

Which is the better prognostic factor for resected non-small cell lung cancer: the number of metastatic lymph nodes or the currently used nodal stage classification?